Exeltis USA
1972
FOUNDED
M&A
STATUS
31-40
EMPLOYEES
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
1
INVESTMENTS
Description
Provider of prescription pharmaceutical and nutraceutical products. The company's products are sold through sales representatives to the eastern United States, as well as several foreign countries. Its main products are vitamins, respiratory care, anti-infective, and pain relief treatments.
Website
Formerly Known As
Everett Laboratories
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Chemo Group
Primary Office
- 29 Spring Street
- West Orange, NJ 07052
- United States
+1 (973) 000-0000
Exeltis USA Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Exeltis USA‘s full profile, request access.
Request full access to PitchBookExeltis USA Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 000 000000 | 16-Dec-2013 | 000000000000000000 | Pharmaceuticals | 00000 000000 |
Exeltis USA Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Exeltis USA‘s full profile, request access.
Request full access to PitchBook